Ovarian stimulation and borderline ovarian tumors: a case-control study

Fertility and Sterility
B J MosgaardA N Andersen

Abstract

To assess the risk of borderline ovarian cancer among infertile women treated with fertility drugs. Case-control study. Nationwide data obtained from public registers and postal questionnaires. All Danish women <60 years old with borderline ovarian cancer during the period 1989-1994 and randomly selected population controls. The analysis included 231 cases and 1,721 controls. None. Influence of parity, infertility, and fertility drugs on the risk of borderline ovarian cancer after multivariate confounder control. The odds ratio (OR) for borderline ovarian cancer among infertile untreated nulliparous women compared with fertile nulliparous women was 1.9. The OR for borderline ovarian cancer among treated nulliparous women compared with untreated infertile nulliparous women was 1.5, and the OR among treated parous women compared with untreated infertile parous women was 1.5. Among fertile women, the difference in the risk of borderline ovarian cancer between nulliparous women and parous women was not statistically significant. Nulliparous women who were infertile and who did not receive medical treatment had a twofold higher risk of borderline ovarian cancer than fertile nulliparous women. There was no statistically significant i...Continue Reading

References

Jul 28, 1979·Lancet·J T CasagrandeB E Henderson
Feb 1, 1979·Cancer·J F AnnegersW M O'Fallon
Dec 1, 1991·International Journal of Epidemiology·F ParazziniC Mangioni
Jan 1, 1989·Journal of Cancer Research and Clinical Oncology·E MohtashamipurF Lühmann
Jul 1, 1989·American Journal of Obstetrics and Gynecology·P HartgeH J Norris
Sep 1, 1995·Acta Obstetricia Et Gynecologica Scandinavica·B MosgaardA N Andersen
May 11, 1995·The New England Journal of Medicine·G Del PrioreW R Phipps
Sep 22, 1994·The New England Journal of Medicine·M A RossingS G Self
Jan 1, 1993·Journal of Clinical Epidemiology·D Salsburg
Dec 1, 1995·British Journal of Obstetrics and Gynaecology·L SchmidtP Helm
Jun 1, 1997·Fertility and Sterility·B J MosgaardA N Andersen

❮ Previous
Next ❯

Citations

Mar 19, 2013·Archives of Gynecology and Obstetrics·Susanne SchülerOlaf Ortmann
May 22, 2003·Best Practice & Research. Clinical Obstetrics & Gynaecology·Alison VennRobert McLachlan
Jan 11, 2000·Clinical Obstetrics and Gynecology·L J Wolf
May 8, 2008·Current Opinion in Obstetrics & Gynecology·Tony G ZreikAdnan R Munkarah
Feb 1, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·I Konishi
Apr 10, 2010·Obstetrics and Gynecology International·Tosin AjalaRichard Howell
Jun 19, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Michelle L KurtaBrenda Diergaarde
Oct 13, 2009·Gynécologie, obstétrique & fertilité·M KoskasC Yazbeck
Mar 28, 2008·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Fariba SalehiBarbara C Vanderhyden
Jan 23, 2013·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Ritsa StorengNan Birgitte Oldereid
Feb 7, 2013·Gynecologic Oncology·Louise M StewartRoger Hart
Jan 14, 2016·Human Reproduction Update·Ignacio ZapardielJuan A Garcia-Velasco
Oct 5, 2011·BJOG : an International Journal of Obstetrics and Gynaecology·G K SiddiquiJ C Dornan
Sep 6, 2012·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Angiolo GadducciAndrea Riccardo Genazzani
Apr 5, 2013·Fertility and Sterility·Albert AsanteCharles C Coddington
Jul 19, 2016·Cancer Treatment Reviews·Giorgia MangiliFedro Peccatori
Nov 5, 2016·Fertility and Sterility·UNKNOWN Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, UNKNOWN Practice Committee of the American Society for Reproductive Medicine
Apr 4, 2006·Fertility and Sterility·Ali MahdaviFarr Nezhat
May 26, 2017·Current Opinion in Obstetrics & Gynecology·Lindsay KroenerZain Al-Safi
Aug 15, 2013·The Cochrane Database of Systematic Reviews·Ivana RizzutoLesley A Smith
Mar 31, 2004·Obstetrics and Gynecology·Sonya KashyapZev Rosenwaks
Jul 11, 2006·The Journal of Family Planning and Reproductive Health Care·Karim Elmasry, Simon A Gayther
Aug 19, 2007·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Maite CusidóPere Nolsac Barri
Jun 18, 2019·The Cochrane Database of Systematic Reviews·Ivana RizzutoLesley A Smith
Apr 23, 2014·Current Opinion in Obstetrics & Gynecology·Brenda Diergaarde, Michelle L Kurta
Feb 7, 2001·Current Opinion in Obstetrics & Gynecology·K E Wakeley, E C Grendys
Feb 15, 2002·Human Fertility : Journal of the British Fertility Society·David H. Barlow
Jun 14, 2019·Frontiers in Endocrinology·Zohre MomenimovahedHamid Salehiniya
Nov 19, 2004·Acta Obstetricia Et Gynecologica Scandinavica·Ali AyhanMurat Gultekin
Jan 22, 2017·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Marte Myhre ReigstadInger Kristin Larsen
Dec 15, 2020·Oncotarget·David A LandryBarbara C Vanderhyden
Feb 16, 2021·Human Reproduction·Jennifer Frances BarcroftSrdjan Saso

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved